Sun Pharmaceutical Industries Limited (SUNPHARMA) — Announcement | 25 August 2026

· NSE Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Company announces analyst meeting schedule for September 2026
💡 Investor Takeaway
Investors can attend scheduled meetings to hear updates but should note no price-sensitive information will be shared.

Sun Pharmaceutical announced its upcoming analyst and institutional investor meeting schedule on August 25, 2026, with the first session set for September 1 at the Elara India Dialogue 2026 conference in Mumbai, offering group and one-on-one formats while clarifying no UPSI will be disclosed during these events.

📄 View Original Announcement (PDF)

About Sun Pharmaceutical Industries Limited (SUNPHARMA)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹4,69,309.92 Cr P/E: 38.8 ROE: 14.6% ROCE: 18.7% Div Yield: 0.82%

View full SUNPHARMA stock details →

📡 Get AI alerts when SUNPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SUNPHARMA — Free

📊 More SUNPHARMA filings

See all SUNPHARMA filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when SUNPHARMA files new disclosures

Track SUNPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track SUNPHARMA — Free

Free account · 2 AI queries/day